Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

CVS Health has eliminated more than 1,000 jobs based at or reporting to its offices in Hartford, which include the ...

Lynch has good reasons and shows a practical approach to using inventories to monitor the health and efficiency of the target business. Along these lines, the next figure compares CVS and WBA’s ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella. For the second day in a row, CVS Health's (NYSE: CVS) stock price saw a ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

"At CVS Pharmacy, we are committed to offering products that are safe, high quality, meet our customers' health and wellness needs, and comply with laws and regulations. The health and safety of ...

CVS Health ended 2024 as it started, with high medical costs in the company’s insurance business chipping away at its bottom ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.